EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023
July 05 2023 - 12:00PM
EQUASENS: results of the votes on the resolutions submitted to the
ordinary annual shareholders' meeting of 29 june 2023
Villers-lès-Nancy, 5 July 2023 - 6:00 p.m.
(CET)
PRESS RELEASE
RESULTS OF THE VOTES ON THE RESOLUTIONS
SUBMITTED
TO THE ORDINARY ANNUAL SHAREHOLDERS'
MEETING
OF 29 JUNE 2023
Number of shares comprising the share capital:
15,174,125
Number of shares with voting rights:
15,032,834
Number of shares with voting rights possessed by
shareholders presents or represented or having voted by mail:
13,046,120
That means a quorum of 86.78% of the
15,032,834 shares with voting rights:
the Ordinary Annual General Meeting was able to
deliberate.
The Ordinary Annual General Meeting was held on
Thursday, 29 June 2023 at 5:30 p.m. at the Company’s headquarters
and approved the separate parent company and consolidated financial
statements for the 2022 financial year. The results of the votes on
the resolutions proposed at this meeting by the Board of Directors
were as follows:
Resolutions |
Results of the votes |
Approval of the annual financial statements |
Resolution adopted by:
- 13,044,237 votes in favour
- 0 vote against
- 1,883 abstentions
|
Discharge of directors and discharge of the Statutory Auditors for
the performance of their engagement |
Resolution adopted by:
- 12,943,792 votes in favour
- 100,445 votes against
- 1,883 abstentions
|
- RESOLUTION THREEApproval of the
consolidated financial statements
|
Resolution adopted by:
- 13,044,237 votes in favour
- 0 vote against
- 1,883 abstentions
|
Appropriation of earnings, setting the dividend |
Resolution adopted by:
- 13,046,120 votes in favour
- 0 vote against
- 0 abstention
|
Agreements and commitments governed by Articles L. 225-38 of the
French Commercial Code |
Resolution adopted by (*):
- 12,983,939 votes in favour
- 62,072 votes against
- 99 abstentions
|
Renewal of Ms. Anne LHOTE's term of office as Director |
Resolution adopted by:
- 10,706,967 votes in favour
- 2,339,153 votes against
- 0 abstention
|
Renewal of Ms. Céline GRIS's term of office as Independant
Director |
Resolution adopted by:
- 11,112,739 votes in favour
- 1,933,381 votes against
- 0 abstention
|
Renewal of Ms. Émilie LECOMTE's term of office as Director |
Resolution adopted by:
- 10,723,209 votes in favour
- 2,322,911 votes against
- 0 abstention
|
Appointment of a new Director |
Resolution adopted by:
- 12,902,756 votes in favour
- 143,364 votes against
- 0 abstention
|
Appointment of a new Statutory Auditor |
Resolution adopted by:
- 13,040,577 votes in favour
- 5,543 votes against
- 0 abstention
|
Approval of the information on the compensation of corporate
officers paid in or granted for fiscal 2022 and mentioned in
Article L. 22-10-9 of the French Commercial Code |
Resolution adopted by:
- 12,095,451 votes in favour
- 950,669 votes against
- 0 abstention
|
Approval of the components of compensation paid in 2022 to Mr.
Thierry CHAPUSOT, Chairman of the Board of Directors |
Resolution adopted by:
- 13,033,420 votes in favour
- 12,700 votes against
- 0 abstention
|
Approval of the components of compensation paid in 2022 to Mr.
Dominique PAUTRAT, Chief Executive Officer |
Resolution adopted by:
- 10,746,386 votes in favour
- 2,299,734 votes against
- 0 abstention
|
Approval of the components of compensation paid in 2022 to Mr.
Denis SUPPLISSON, Deputy Chief Executive Officer and then Chief
Executive Officer |
Resolution adopted by:
- 10,592,005 votes in favour
- 2,454,115 votes against
- 0 abstention
|
Approval of the components of compensation paid in 2022 to Mr.
Grégoire DE ROTALIER, Deputy CEO |
Resolution adopted by:
- 10,592,005 votes in favour
- 2,454,115 votes against
- 0 abstention
|
Approval of the compensation policy for the Chairman of the Board
of Directors for 2023 |
Resolution adopted by:
- 13,033,420 votes in favour
- 12,700 votes against
- 0 abstention
|
Approval of the compensation policy for Mr. Denis SUPPLISSON, Chief
Executive Officer, for 2023 |
Resolution adopted by:
- 10,759,416 votes in favour
- 2,286,704 votes against
- 0 abstention
|
Approval of the compensation policy for Mr. Grégoire de ROTALIER,
Deputy Chief Executive Officer, for 2023 |
Resolution adopted by:
- 10,759,416 votes in favour
- 2,286,704 votes against
- 0 abstention
|
Approval of the compensation policy for Directors |
Resolution adopted by:
- 13,044,420 votes in favour
- 1,700 votes against
- 0 abstention
|
Setting total annual compensation for Directors for 2023 |
Resolution adopted by:
- 13,044,420 votes in favour
- 1,700 votes against
- 0 abstention
|
Authorisation by the Company to repurchase its own shares |
Resolution adopted by:
- 11,101,214 votes in favour
- 1,944,906 vote against
- 0 abstention
|
Powers for formalities |
Resolution adopted by:
- 13,046,120 votes in favour
- 0 vote against
- 0 abstention
|
(*) After deduction of excluded voting
rights
Financial Calendar:
- Publication of H1
2023 Revenue: 3 August
2023, after French market closure.
About Group Equasens
Founded more than 35 years ago, Equasens Group,
which now has more than 1,200 employees in Europe, is the leading
publisher of software solutions for the healthcare industry in
terms of the diversity of its business applications and market
share.
Equasens Group’s specialised business
applications facilitate the day-to-day work of healthcare
professionals and their teams, working in private practice,
collaborative medical structures or healthcare establishments. The
Group also provides comprehensive support to healthcare
professionals in the transformation of their profession by
developing electronic equipment, digital solutions and healthcare
robotics, as well as financing and training adapted to their
specific needs.
And reflecting the spirit of its tagline "
technology for a more human experience", the Group is a leading
provider of interoperability solutions that improve coordination
between healthcare professionals, their communications and data
exchange resulting in better patient care and a more efficient
healthcare system.
Listed on Euronext Paris™ - Compartment A
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020
- CAC® SMALL and CAC® All-TradableIncluded in the Euronext Tech
Leaders segment and the European Rising Tech label
Eligible for the Deferred Settlement Service (“Service à
Règlement Différé” - SRD) and equity savings accounts invested in
small and mid caps (PEA-PME)ISIN: FR 0012882389 – Ticker Code:
EQS
Get all the news about the Equasens Group
www.equasens.com and on
LinkedIn
CONTACTS
Analyst and Investor
Relations: Chief Administrative and Financial Officer:
Frédérique SCHMIDTTel. +33 (0)3 83 15 90 67 -
frederique.schmidt@equasens.com
Media Relations:
FIN’EXTENSO - Isabelle APRILE
Tel. +33 (0)6 17
38 61 78 - i.aprile@finextenso.fr
- EQUASENS_PRESSRELEASE_20230705_RESULTS OF THE VOTES_en_US
Equasens (EU:EQS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Equasens (EU:EQS)
Historical Stock Chart
From Sep 2023 to Sep 2024